BWP
MEDP icon

Balboa Wealth Partners’s Medpace MEDP Stock Holding History

Balboa Wealth Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
811
-14
-2% -$6.46K 0.06% 262
2026
Q1 		$396K Buy
825
+225
+38% +$115K 0.07% 243
2025
Q4 		$337K Buy
600
+42
+8% +$23.8K 0.06% 260
2025
Q3 		$287K Buy
+558
New +$244K 0.05% 279
2025
Q1 		– Sell
-604
Closed -$201K – 357
2024
Q4 		$201K Buy
+604
New +$205K 0.05% 279

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Balboa Wealth Partners's MEDP Position: Q2 2026 in Review

Balboa Wealth Partners reduced its Medpace (MEDP) stake by 1.7% in Q2 2026, selling an estimated $6.46K and leaving 811 shares worth $429K. The position accounts for 0.06% of the portfolio, ranked #262.

Balboa Wealth Partners first reported a position in MEDP in Q4 2024 and has held it in 5 quarters since. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Balboa Wealth Partners held 811 shares of Medpace worth $429K as of Q2 2026.
  • Balboa Wealth Partners sold 14 Medpace shares in Q2 2026, an estimated $6.46K.
  • Medpace made up 0.06% of Balboa Wealth Partners's portfolio in Q2 2026, its #262 holding.
  • Balboa Wealth Partners first reported a position in Medpace in Q4 2024 and has held it in 5 quarters since.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.